ArticleAsian Pacific journal of cancer prevention : APJCP2022

Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.

Shinya Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.